Dalfampridine Market – Extended-Release Therapy Improving...

σε πρόσθεσε στο Health

2026-09-15 10:34:29 -

Dalfampridine Market – Extended-Release Therapy Improving Walking Ability in Multiple Sclerosis

Market Overview The dalfampridine market continues to hold clinical relevance as this extended-release potassium channel blocker remains a recognized option for improving walking ability in patients with multiple sclerosis. Unlike disease-modifying therapies, dalfampridine addresses a specific functional symptom, offering measurable mobility improvement for eligible patients. The Dalfampridine...

0 Σχόλια 0 Μοιράστηκε 7 Views 0 Προεπισκόπηση